These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12207869)

  • 21. Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans.
    Sumi M; Watari N; Umezawa O; Kaneniwa N
    J Pharmacobiodyn; 1987 Nov; 10(11):652-61. PubMed ID: 3446773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
    Dutta S; Reed RC; O'Dea RF
    Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
    Glue P; Fang A; Gandelman K; Klee B
    Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
    Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
    Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postinduction carbamazepine clearance in an adult psychiatric population.
    Martin ES; Crismon ML; Godley PJ
    Pharmacotherapy; 1991; 11(4):296-302. PubMed ID: 1923910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
    Kovacević I; Parojcić J; Homsek I; Tubić-Grozdanis M; Langguth P
    Mol Pharm; 2009; 6(1):40-7. PubMed ID: 19248231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate--a single dose pharmacokinetic study in human volunteers.
    Kulkarni C; Vaz J; David J; Joseph T
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):122-6. PubMed ID: 7649598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
    Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
    J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.